Table 1. Representation of predicted and validated miRNAs targeting Eph receptors and ephrin ligands.
Ephrin/ Eph receptor | Position: 5′-3′ of 3′-UTR | Predicted miRNA binding |
---|---|---|
EphrinA1 |
235–241 |
miR-9 miR-22385 miR-122, miR-451 and miR-2786 |
EphrinA2 |
NA |
NA miR-122, miR-451 and miR-2786 |
EphrinA3 |
467–173, 474–480, 791–797 |
miR-30, miR-130, miR-153 miR-21087 |
EphrinA4 |
NA* |
NA* |
EphrinA5 |
NA |
NA |
EphrinA6 |
NA* |
NA* |
EphrinA7 |
NA* |
NA* |
EphrinB1 |
195–201 |
miR-124
77
|
EphrinB2 |
1880–1886, 2871–2877, 2952–2958, 3078–3084, |
miR-153, miR-182, miR-200, miR-1 and miR-206, |
EphrinB3 |
901–907 |
miR-124 |
EphA1 |
106–112 |
miR-29 |
EphA2 |
24–30 729–735 |
miR-2689 miR-141 and miR-200 |
EphA3 |
NA* |
NA* |
EphA4 |
36–42, 48–54 |
let-7, miR-17 |
EphA5 |
NA* |
NA* |
EphA6 |
NA* |
NA* |
EphA7 |
776–782, 1815–1821, 1817–1823 |
miR-137, miR-133, miR-9 |
EphA8 |
550–556, 1162–1168, 1322–1328, 1323–1329 |
miR-138, miR-218, miR-25/32/92, miR-137 |
EphA9 |
NA |
NA |
EphB1 |
NA* |
NA* |
EphB2 |
1403–1409 |
miR-128 |
EphB3 |
775–781 |
miR-137 |
EphB4 |
107–113, 317–323, 318–324 |
miR-17/93/106, miR-133, miR-9 |
EphB5 |
NA |
NA |
EphB6 | NA* | NA* |
Predictions of the 5′-3′ mRNA sequence position and corresponding miRNA are assessed by TargetScan 5.1. Sites shown have a high probability of preferential conservation between human, rhesus, chimpanzee and mouse. Potential miRNAs derived from experimental evidence are italicized. Validated miRNAs are in bold. NA, Eph receptor or ephrin ligand gene not in TargetScan database; NA*, no highly conserved sites.